Literature DB >> 17487334

Causes and characteristics of diabetic cardiomyopathy.

Jianxun Wang1, Ye Song, Qianwen Wang, Patricia M Kralik, Paul N Epstein.   

Abstract

Type 1 and type 2 diabetic patients are at increased risk of cardiomyopathy and heart failure is a major cause of death for these patients. Cardiomyopathy in diabetes is associated with a cluster of features including decreased diastolic compliance, interstitial fibrosis and myocyte hypertrophy. The mechanisms leading to diabetic cardiomyopathy remain uncertain. Diabetes is associated with most known risk factors for cardiac failure seen in the overall population, including obesity, dyslipidemia, thrombosis, infarction, hypertension, activation of multiple hormone and cytokine systems, autonomic neuropathy, endothelial dysfunction and coronary artery disease. In light of these common contributing pathologies it remains uncertain whether diabetic cardiomyopathy is a distinct disease. It is also uncertain which factors are most important to the overall incidence of heart failure in diabetic patients. This review focuses on factors that can have direct effects on diabetic cardiomyocytes: hyperglycemia, altered fuel use, and changes in the activity of insulin and angiotensin. Particular attention is given to the changes these factors can have on cardiac mitochondria and the role of reactive oxygen species in mediating injury to cardiomyocytes.

Entities:  

Year:  2006        PMID: 17487334      PMCID: PMC1783586          DOI: 10.1900/RDS.2006.3.108

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  85 in total

1.  No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitus.

Authors:  M Romanens; S Fankhauser; B Saner; L Michaud; H Saner
Journal:  Eur J Heart Fail       Date:  1999-06       Impact factor: 15.534

Review 2.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

Authors:  M M Awan; E D Saggerson
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

Review 4.  Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

Authors:  D S Bell
Journal:  Diabetes Care       Date:  1995-05       Impact factor: 19.112

5.  Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.

Authors:  Xia Shen; Shirong Zheng; Visith Thongboonkerd; Ming Xu; William M Pierce; Jon B Klein; Paul N Epstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-27       Impact factor: 4.310

6.  Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney.

Authors:  Boli Huang; Pengfei Wu; Kirill M Popov; Robert A Harris
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

7.  Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus.

Authors:  S Nunoda; A Genda; N Sugihara; A Nakayama; S Mizuno; R Takeda
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

Review 8.  Cardiac consequences of diabetes mellitus.

Authors:  A Shehadeh; T J Regan
Journal:  Clin Cardiol       Date:  1995-06       Impact factor: 2.882

9.  Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo.

Authors:  R R Russell; R Yin; M J Caplan; X Hu; J Ren; G I Shulman; A J Sinusas; L H Young
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

10.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

Authors:  R D Abbott; R P Donahue; W B Kannel; P W Wilson
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

View more
  42 in total

Review 1.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.

Authors:  Guanghong Jia; Adam Whaley-Connell; James R Sowers
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Maternal obesity induces fibrosis in fetal myocardium of sheep.

Authors:  Yan Huang; Xu Yan; Jun X Zhao; Mei J Zhu; Richard J McCormick; Stephen P Ford; Peter W Nathanielsz; Jun Ren; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-28       Impact factor: 4.310

3.  Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.

Authors:  Ning Zhang; Zheng Yang; Shi-Zhao Xiang; Ya-Ge Jin; Wen-Ying Wei; Zhou-Yan Bian; Wei Deng; Qi-Zhu Tang
Journal:  Mol Cell Biochem       Date:  2016-05-10       Impact factor: 3.396

Review 4.  Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation.

Authors:  Mohamed F El-Refaei; Suha H Abduljawad; Ahmed H Alghamdi
Journal:  Rev Diabet Stud       Date:  2015-02-10

5.  Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.

Authors:  Rita M Maalouf; Assaad A Eid; Yves C Gorin; Karen Block; Gladys Patricia Escobar; Steven Bailey; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

6.  Global Nature of Incipient Chamber Remodeling and Dysfunction in Diabetic Individuals Living in the Community: Potential Mechanisms.

Authors:  Eric Xie; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-16       Impact factor: 7.792

Review 7.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

Review 8.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 9.  Shotgun lipidomics of neutral lipids as an enabling technology for elucidation of lipid-related diseases.

Authors:  Richard W Gross; Xianlin Han
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-06       Impact factor: 4.310

Review 10.  Proteasome biology and therapeutics in cardiac diseases.

Authors:  Sanket Kumar Shukla; Khadija Rafiq
Journal:  Transl Res       Date:  2018-09-28       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.